- Home
- ATEX vs INNV Comparison
ATEX vs INNV Comparison
Compare ATEX & INNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATEX | INNV |
|---|---|---|
| Founded | 1997 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medical/Nursing Services |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 508.3M | 485.4M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | ATEX | INNV |
|---|---|---|
| Price | $28.39 | $8.47 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 2 | 1 |
| Target Price | ★ $58.50 | $5.00 |
| AVG Volume (30 Days) | ★ 368.8K | 252.0K |
| Earning Date | 02-11-2026 | 02-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 5.13 | 0.05 |
| Revenue | $5,925,000.00 | ★ $915,371,000.00 |
| Revenue This Year | $6.22 | $11.18 |
| Revenue Next Year | $4.31 | $9.58 |
| P/E Ratio | ★ $5.53 | $174.85 |
| Revenue Growth | 5.67 | ★ 13.48 |
| 52 Week Low | $17.58 | $2.60 |
| 52 Week High | $42.91 | $8.40 |
Technical Indicators
Market Signals| Indicator | ATEX | INNV |
|---|---|---|
| Relative Strength Index (RSI) | 58.83 | 71.69 |
| Support Level | $25.49 | $5.38 |
| Resistance Level | $28.03 | $8.09 |
| Average True Range (ATR) | 1.70 | 0.45 |
| MACD | 0.04 | 0.20 |
| Stochastic Oscillator | 50.80 | 83.76 |
Price Performance
Historical ComparisonAbout ATEX Anterix Inc.
Anterix Inc is a United States-based company engaged in delivering broadband needed to modernize infrastructure for energy, transportation, logistics, and other industries. The company offers Private LTE for utilities which help to automate processes, monitor environmental conditions, enable artificial intelligence, and drive productivity.
About INNV InnovAge Holding Corp.
InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.